{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["37(8)"],"submitter":["Khan U"],"pubmed_abstract":["Decentralized, person-centred models of care delivery for drug-resistant tuberculosis (DR-TB) continue to be under-resourced in high-burden TB countries. The implementation of such models-made increasingly urgent by the COVID-19 pandemic-are key to addressing gaps in DR-TB care. We abstracted data of rifampicin-resistant (RR)/multidrug-resistant tuberculosis (MDR-TB) patients initiated on treatment at 11 facilities between 2010 and 2017 in Sindh and Balochistan provinces of Pakistan. We analysed trends in treatment outcomes relating to programme expansion to peri-urban and rural areas and estimated driving distance from patient residence to treatment facility. Among the 5586 RR/MDR-TB patients in the analysis, overall treatment success decreased from 82% to 66% between 2010 and 2017, as th"],"journal":["Health policy and planning"],"pagination":["979-989"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9384034"],"repository":["biostudies-literature"],"pubmed_title":["Re-evaluating the merits of decentralization as a core strategy for effective delivery of drug-resistant tuberculosis care in Pakistan."],"pmcid":["PMC9384034"],"pubmed_authors":["Butt S","Khan AB","Ahmed S","Parekh A","Akhtar A","Lotia-Farrukh I","Khowaja SN","Siddiqui MR","Khan AJ","Khan PY","Madhani F","Jamal S","Chaudhry M","Keshavjee S","Salahuddin N","Ijaz R","Hussain H","Khan U","Adnan S","Khan S","Habib A"],"additional_accession":[]},"is_claimable":false,"name":"Re-evaluating the merits of decentralization as a core strategy for effective delivery of drug-resistant tuberculosis care in Pakistan.","description":"Decentralized, person-centred models of care delivery for drug-resistant tuberculosis (DR-TB) continue to be under-resourced in high-burden TB countries. The implementation of such models-made increasingly urgent by the COVID-19 pandemic-are key to addressing gaps in DR-TB care. We abstracted data of rifampicin-resistant (RR)/multidrug-resistant tuberculosis (MDR-TB) patients initiated on treatment at 11 facilities between 2010 and 2017 in Sindh and Balochistan provinces of Pakistan. We analysed trends in treatment outcomes relating to programme expansion to peri-urban and rural areas and estimated driving distance from patient residence to treatment facility. Among the 5586 RR/MDR-TB patients in the analysis, overall treatment success decreased from 82% to 66% between 2010 and 2017, as th","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-18T15:25:00.993Z","creation":"2024-11-09T05:30:36.92Z"},"accession":"S-EPMC9384034","cross_references":{"pubmed":["35527232"],"doi":["10.1093/heapol/czac038"]}}